KBL697

· KoBioLabs

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KBL697, covering 2025-01-07 to 2025-01-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis [Phase 2]